A panel of advisers to the U.S. Food and Drug Administration on Friday voted to recommend the authorization of a second dose of Johnson & Johnson's COVID-19 vaccine for people aged 18 and older at least two months after the first dose.
U.S. FDA advisers vote in favor of booster for J&J COVID-19 vaccine
Reuters | Oct 15, 2021 11:32 PM EDT
A vial of Johnson & Johnson's Janssen coronavirus disease (COVID-19) vaccine is seen during a vaccination event hosted by Miami - Dade County and Miami Heat, at FTX Arena in Miami, Florida, U.S.,
Most Popular
-
The Game Beyond the Game: A Guide to Understanding Betting Odds
-
Beyond the Buzz: Demystifying Bitcoin and Its Potential Impact
-
Exploring the Future of Online Gaming and Financial Innovations
-
The Allure of Crypto Gambling: Diving into the World of Bitcoin Casinos
-
Discover the Secrets to Consistent Online Casino Wins
-
Enhancing User Experience through Customer Service